Vanderbilt University
Vanderbilt University
Nashville, Tennessee, United States7 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis | Coronary Artery Disease Progression; Coronary Artery Disease Risk Factors Multiple; Premature Atherosclerosis; Prevention & Control | Recruiting | Phase 3 | 2026-10-07 | NCT07232069 | |
| Optimal Stent Duration After Ureteroscopy | Ureteral Stent | Active, not recruiting | Not applicable | 2026-09-17 | NCT06045962 | |
| Drumming Lessons' Influence on Children With Down Syndrome | Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Down syndrome, Neurobehavioral Manifestations, Neurologic Manifestations, chromosomal disorder, hereditary disease, intellectual disability, nervous system disorder | Recruiting | Not applicable | 2026-05-19 | NCT07156318 | |
| The Healing and Empowerment Actions for Recovery From Trauma (HEART) Trial | Wounds, Nonpenetrating, injury | Not yet recruiting | Not applicable | 2026-05-13 | NCT07584252 | |
| Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Recruiting | Not applicable | 2026-03-23 | NCT06919224 | |
| Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, alveolar soft part sarcoma, connective tissue neoplasm, leiomyosarcoma, myomatous neoplasm, neoplasm, sarcoma, synovial sarcoma | Recruiting | Phase 3 | 2026-02-25 | NCT03016819 | |
| Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 3 | 2026-01-22 | NCT01208662 |